<h3>漲幅榜</h3>
<ul>
<li><strong>Tandem Diabetes Care</strong> (NASDAQ: TNDM) 股票在週五的常規交易中上漲了 35.0%，達到 $25.0。其流通股的市值為 12 億美元。根據消息，第四季度財報昨日發佈。</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) 股票上漲了 22.21%，達到 $0.11。</li>
<li><strong>Cardio Diagnostics Hldgs</strong> (NASDAQ: CDIO) 股票上漲了 19.64%，達到 $2.68。其流通股的市值為 400 萬美元。</li>
<li><strong>enVVeno Medical</strong> (NASDAQ: NVNO) 股票上漲了 18.11%，達到 $11.8。其流通股的市值為 650 萬美元。</li>
<li><strong>Nasus Pharma</strong> (AMEX: NSRX) 股票上漲了 18.0%，達到 $5.9。公司的市值為 5870 萬美元。</li>
<li><strong>Sensei Biotherapeutics</strong> (NASDAQ: SNSE) 股票上漲了 16.86%，達到 $31.81。公司的市值為 3430 萬美元。</li>
</ul>
<h3>跌幅榜</h3>
<ul>
<li><strong>GRAIL</strong> (NASDAQ: GRAL) 股票在週五的常規交易中下跌了 47.8%，達到 $53.02。其流通股的市值為 39 億美元。根據消息，第四季度財報昨日發佈。</li>
<li><strong>Dermata Therapeutics</strong> (NASDAQ: DRMA) 股票下跌了 25.86%，達到 $1.43。公司的市值為 540 萬美元。</li>
<li><strong>BioRestorative Therapies</strong> (NASDAQ: BRTX) 股票下跌了 15.75%，達到 $0.23。其流通股的市值為 620 萬美元。</li>
<li><strong>Candel Therapeutics</strong> (NASDAQ: CADL) 股票下跌了 14.54%，達到 $5.08。其流通股的市值為 3.266 億美元。</li>
<li><strong>Harmony Biosciences Hldgs</strong> (NASDAQ: HRMY) 股票下跌了 13.67%，達到 $29.69。公司的市值為 19 億美元。</li>
<li><strong>Regencell Bioscience</strong> (NASDAQ: RGC) 股票下跌了 12.3%，達到 $29.34。公司的市值為 165 億美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>

美國醫藥設備 ETF - iShares

基因改革 ETF - ARK

2 倍做空衞生保健 ETF - ProShares

<p>在週五的交易中，Tandem Diabetes Care (TNDM) 的股價上漲了 35%，達到 25 美元，此次上漲是在其第四季度財報發佈後發生的。同時，Bristol-Myers Squibb 的 Celgene CVR (CELGR) 上漲了 22.21%，至 0.11 美元。其他顯著上漲的股票包括 Cardio Diagnostics (CDIO) 上漲 19.64%，enVVeno Medical (NVNO) 上漲 18.11%，以及 Nasus Pharma (NSRX) 上漲 18%。相反，GRAIL (GRAL) 的股價大幅下跌 47.8%，至 53.02 美元，Dermata Therapeutics (DRMA) 下跌 25.86%，BioRestorative Therapies (BRTX) 下跌 15.75%</p>

<h3>Gainers</h3>
<div class="lb-trans"><h3>漲幅榜</h3>
</div><ul>
<li><strong>Tandem Diabetes Care</strong> (NASDAQ: TNDM) stock increased by 35.0% to $25.0 during Friday's regular session. The market value of their outstanding shares is at $1.2 billion. As per the news, the Q4 earnings report came out yesterday.</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) stock rose 22.21% to $0.11.</li>
<li><strong>Cardio Diagnostics Hldgs</strong> (NASDAQ: CDIO) stock increased by 19.64% to $2.68. The market value of their outstanding shares is at $4.0 million.</li>
<li><strong>enVVeno Medical</strong> (NASDAQ: NVNO) shares increased by 18.11% to $11.8. The market value of their outstanding shares is at $6.5 million.</li>
<li><strong>Nasus Pharma</strong> (AMEX: NSRX) shares moved upwards by 18.0% to $5.9. The company's market cap stands at $58.7 million.</li>
<li><strong>Sensei Biotherapeutics</strong> (NASDAQ: SNSE) stock increased by 16.86% to $31.81. The company's market cap stands at $34.3 million.</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>Tandem Diabetes Care</strong> (NASDAQ: TNDM) 股票在週五的常規交易中上漲了 35.0%，達到 $25.0。其流通股的市值為 12 億美元。根據消息，第四季度財報昨日發佈。</li>
<li><strong>Bristol-Myers Squibb Company Celegne Contingent Value Rights</strong> (NYSE: CELGR) 股票上漲了 22.21%，達到 $0.11。</li>
<li><strong>Cardio Diagnostics Hldgs</strong> (NASDAQ: CDIO) 股票上漲了 19.64%，達到 $2.68。其流通股的市值為 400 萬美元。</li>
<li><strong>enVVeno Medical</strong> (NASDAQ: NVNO) 股票上漲了 18.11%，達到 $11.8。其流通股的市值為 650 萬美元。</li>
<li><strong>Nasus Pharma</strong> (AMEX: NSRX) 股票上漲了 18.0%，達到 $5.9。公司的市值為 5870 萬美元。</li>
<li><strong>Sensei Biotherapeutics</strong> (NASDAQ: SNSE) 股票上漲了 16.86%，達到 $31.81。公司的市值為 3430 萬美元。</li>
</ul>
</div><h3>Losers</h3>
<div class="lb-trans"><h3>跌幅榜</h3>
</div><ul>
<li><strong>GRAIL</strong> (NASDAQ: GRAL) stock fell 47.8% to $53.02 during Friday's regular session. The market value of their outstanding shares is at $3.9 billion. As per the news, the Q4 earnings report came out yesterday.</li>
<li><strong>Dermata Therapeutics</strong> (NASDAQ: DRMA) shares decreased by 25.86% to $1.43. The company's market cap stands at $5.4 million.</li>
<li><strong>BioRestorative Therapies</strong> (NASDAQ: BRTX) shares declined by 15.75% to $0.23. The market value of their outstanding shares is at $6.2 million.</li>
<li><strong>Candel Therapeutics</strong> (NASDAQ: CADL) shares declined by 14.54% to $5.08. The market value of their outstanding shares is at $326.6 million.</li>
<li><strong>Harmony Biosciences Hldgs</strong> (NASDAQ: HRMY) shares fell 13.67% to $29.69. The company's market cap stands at $1.9 billion.</li>
<li><strong>Regencell Bioscience</strong> (NASDAQ: RGC) shares decreased by 12.3% to $29.34. The company's market cap stands at $16.5 billion.
<strong>See Also:</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>GRAIL</strong> (NASDAQ: GRAL) 股票在週五的常規交易中下跌了 47.8%，達到 $53.02。其流通股的市值為 39 億美元。根據消息，第四季度財報昨日發佈。</li>
<li><strong>Dermata Therapeutics</strong> (NASDAQ: DRMA) 股票下跌了 25.86%，達到 $1.43。公司的市值為 540 萬美元。</li>
<li><strong>BioRestorative Therapies</strong> (NASDAQ: BRTX) 股票下跌了 15.75%，達到 $0.23。其流通股的市值為 620 萬美元。</li>
<li><strong>Candel Therapeutics</strong> (NASDAQ: CADL) 股票下跌了 14.54%，達到 $5.08。其流通股的市值為 3.266 億美元。</li>
<li><strong>Harmony Biosciences Hldgs</strong> (NASDAQ: HRMY) 股票下跌了 13.67%，達到 $29.69。公司的市值為 19 億美元。</li>
<li><strong>Regencell Bioscience</strong> (NASDAQ: RGC) 股票下跌了 12.3%，達到 $29.34。公司的市值為 165 億美元。
<strong>另見：</strong> www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
</div><p>This article was generated by Benzinga's automated content engine and reviewed by an editor.</p>
<div class="lb-trans"><p>本文由 Benzinga 的自動內容引擎生成，並由編輯審核。</p>
</div>

12 只醫療保健股票在週五盤中交易中出現波動